{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T11:40:49Z","timestamp":1793878849269,"version":"4.7.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T00:00:00Z","timestamp":1637539200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005713","name":"TU Munich","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005713","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.bioorg.2021.105505","type":"journal-article","created":{"date-parts":[[2021,11,20]],"date-time":"2021-11-20T07:02:19Z","timestamp":1637391739000},"page":"105505","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["A novel Cereblon E3 ligase modulator with antitumor activity in gastrointestinal cancer"],"prefix":"10.1016","volume":"119","author":[{"given":"Svenja","family":"Lier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Sellmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Orben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Heinzlmeir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Krau\u00df","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Schneeweis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zonera","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolin","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arlett","family":"Patricia Gloria Sch\u00e4fer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herwig","family":"Pongratz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Engleitner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupert","family":"\u00d6llinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Kuisl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Bassermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Schlag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Dove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Kuster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Rad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Reichert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Wirth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"Saur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siavosh","family":"Mahboobi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcnter","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.bioorg.2021.105505_b0005","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/s41573-019-0047-y","article-title":"Targeted protein degradation: expanding the toolbox","volume":"18","author":"Schapira","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"issue":"10","key":"10.1016\/j.bioorg.2021.105505_b0010","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/s41589-019-0362-y","article-title":"Development of targeted protein degradation therapeutics","volume":"15","author":"Chamberlain","year":"2019","journal-title":"Nat. Chem. Biol."},{"issue":"3","key":"10.1016\/j.bioorg.2021.105505_b0015","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.molcel.2020.01.010","article-title":"Harnessing the Power of Proteolysis for Targeted Protein Inactivation","volume":"77","author":"Verma","year":"2020","journal-title":"Mol. Cell"},{"issue":"1","key":"10.1016\/j.bioorg.2021.105505_b0020","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.cell.2019.11.031","article-title":"Proteolysis-Targeting Chimeras as Therapeutics and Tools for Biological Discovery","volume":"181","author":"Burslem","year":"2020","journal-title":"Cell"},{"issue":"6241","key":"10.1016\/j.bioorg.2021.105505_b0025","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1126\/science.aab1433","article-title":"Phthalimide conjugation as a strategy for in vivo target protein degradation","volume":"348","author":"Winter","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.bioorg.2021.105505_b0030","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/s42003-018-0105-8","article-title":"Androgen receptor degradation by the proteolysis-targeting chimera ARCC-4 outperforms enzalutamide in cellular models of prostate cancer drug resistance","volume":"1","author":"Salami","year":"2018","journal-title":"Commun. Biol."},{"issue":"11","key":"10.1016\/j.bioorg.2021.105505_b0035","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/s41589-020-00652-y","article-title":"PROTAC-mediated degradation reveals a non-catalytic function of AURORA-A kinase","volume":"16","author":"Adhikari","year":"2020","journal-title":"Nat. Chem. Biol."},{"issue":"6168","key":"10.1016\/j.bioorg.2021.105505_b0040","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1126\/science.1244917","article-title":"The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins","volume":"343","author":"Lu","year":"2014","journal-title":"Science"},{"issue":"6168","key":"10.1016\/j.bioorg.2021.105505_b0045","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1126\/science.1244851","article-title":"Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells","volume":"343","author":"Kr\u00f6nke","year":"2014","journal-title":"Science"},{"issue":"7559","key":"10.1016\/j.bioorg.2021.105505_b0050","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nature14610","article-title":"Lenalidomide induces ubiquitination and degradation of CK1\u03b1 in del(5q) MDS","volume":"523","author":"Kr\u00f6nke","year":"2015","journal-title":"Nature"},{"issue":"20","key":"10.1016\/j.bioorg.2021.105505_b0055","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1200\/JCO.2018.77.9637","article-title":"Next-Generation Drugs Targeting the Cereblon Ubiquitin Ligase","volume":"36","author":"Holstein","year":"2018","journal-title":"J. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.bioorg.2021.105505_b0060","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1158\/1535-7163.MCT-16-0050","article-title":"Concepts to Target MYC in Pancreatic Cancer","volume":"15","author":"Wirth","year":"2016","journal-title":"Mol. Cancer Ther."},{"issue":"1","key":"10.1016\/j.bioorg.2021.105505_b0065","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1146\/annurev-cancerbio-030518-055826","article-title":"Targeting MYC Proteins for Tumor Therapy","volume":"4","author":"Wolf","year":"2020","journal-title":"Annu. Rev. Cancer Biol."},{"key":"10.1016\/j.bioorg.2021.105505_b0070","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s40259-019-00370-5","article-title":"Mission Possible: Advances in MYC Therapeutic Targeting in Cancer","volume":"33","author":"Allen-Petersen","year":"2019","journal-title":"Biodrugs"},{"issue":"40","key":"10.1016\/j.bioorg.2021.105505_b0075","doi-asserted-by":"crossref","first-page":"6151","DOI":"10.1038\/sj.onc.1206641","article-title":"Low molecular weight inhibitors of Myc-Max interaction and function","volume":"22","author":"Yin","year":"2003","journal-title":"Oncogene"},{"issue":"5971","key":"10.1016\/j.bioorg.2021.105505_b0080","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1126\/science.1177319","article-title":"Identification of a Primary Target of Thalidomide Teratogenicity","volume":"327","author":"Ito","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.bioorg.2021.105505_b0085","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkaa306","article-title":"GeneTrail 3: advanced high-throughput enrichment analysis","volume":"48","author":"Gerstner","year":"2020","journal-title":"Nucleic Acids Res."},{"issue":"7757","key":"10.1016\/j.bioorg.2021.105505_b0090","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41586-019-1186-3","article-title":"Next-generation characterization of the Cancer Cell Line Encyclopedia","volume":"569","author":"Ghandi","year":"2019","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.bioorg.2021.105505_b0095","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1038\/ng.3984","article-title":"Computational correction of copy number effect improves specificity of CRISPR\u2013Cas9 essentiality screens in cancer cells","volume":"49","author":"Meyers","year":"2017","journal-title":"Nat. Genet."},{"issue":"2","key":"10.1016\/j.bioorg.2021.105505_b0100","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/nm.4474","article-title":"A small-molecule inhibitor of the ubiquitin activating enzyme for cancer treatment","volume":"24","author":"Hyer","year":"2018","journal-title":"Nat. Med."},{"issue":"26","key":"10.1016\/j.bioorg.2021.105505_b0105","doi-asserted-by":"crossref","first-page":"7124","DOI":"10.1073\/pnas.1521738113","article-title":"PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer","volume":"113","author":"Raina","year":"2016","journal-title":"Proc. National Acad. Sci."},{"issue":"6378","key":"10.1016\/j.bioorg.2021.105505_b0110","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1126\/science.aao2774","article-title":"Patient-derived organoids model treatment response of metastatic gastrointestinal cancers","volume":"359","author":"Vlachogiannis","year":"2018","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.bioorg.2021.105505_b0115","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The Molecular Signatures Database Hallmark Gene Set Collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst."},{"key":"10.1016\/j.bioorg.2021.105505_b0120","article-title":"Translation Termination and Ribosome Recycling in Eukaryotes","volume":"10","author":"Hellen","year":"2018","journal-title":"Csh Perspect. Biol."},{"issue":"7611","key":"10.1016\/j.bioorg.2021.105505_b0125","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nature18611","article-title":"A novel cereblon modulator recruits GSPT1 to the CRL4CRBN ubiquitin ligase","volume":"535","author":"Matyskiela","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2021.105505_b0130","doi-asserted-by":"crossref","unstructured":"M. Ishoey, S. Chorn, N. Singh, M.G. Jaeger, M. Brand, J. Paulk, S. Bauer, M.A. Erb, K. Parapatics, A.C. M\u00fcller, K.L. Bennett, G.F. Ecker, J.E. Bradner, G.E. Winter, Translation Termination Factor GSPT1 Is a Phenotypically Relevant Off-Target of Heterobifunctional Phthalimide Degraders, ACS Chem. Biol. 13 (2018) 553\u2013560. 10.1021\/acschembio.7b00969.","DOI":"10.1021\/acschembio.7b00969"},{"key":"10.1016\/j.bioorg.2021.105505_b0135","doi-asserted-by":"crossref","first-page":"9471","DOI":"10.1021\/acs.jmedchem.9b00846","article-title":"Simple Structural Modifications Converting a Bona fide MDM2 PROTAC Degrader into a Molecular Glue Molecule: A Cautionary Tale in the Design of PROTAC Degraders","volume":"62","author":"Yang","year":"2019","journal-title":"J. Med. Chem."},{"issue":"10","key":"10.1016\/j.bioorg.2021.105505_b0140","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1021\/acschembio.0c00520","article-title":"Selective Degradation of GSPT1 by Cereblon Modulators Identified via a Focused Combinatorial Library","volume":"15","author":"Powell","year":"2020","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.bioorg.2021.105505_b0145","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1182\/blood.2020008676","article-title":"CC-90009, a novel cereblon E3 ligase modulator targets acute myeloid leukemia blasts and leukemia stem cells","volume":"137","author":"Surka","year":"2020","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.bioorg.2021.105505_b0150","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1038\/s41401-020-0367-9","article-title":"The novel cereblon modulator CC-885 inhibits mitophagy via selective degradation of BNIP3L","volume":"41","author":"Hao","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.bioorg.2021.105505_b0155","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.omto.2020.06.013","article-title":"A Cereblon Modulator CC-885 Induces CRBN- and p97-Dependent PLK1 Degradation and Synergizes with Volasertib to Suppress Lung Cancer","volume":"18","author":"Li","year":"2020","journal-title":"Mol. Ther. - Oncolytics."},{"issue":"10","key":"10.1016\/j.bioorg.2021.105505_b0160","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1158\/2159-8290.CD-12-0595","article-title":"PDK1 Signaling Toward PLK1\u2013MYC Activation Confers Oncogenic Transformation, Tumor-Initiating Cell Activation, and Resistance to mTOR-Targeted Therapy","volume":"3","author":"Tan","year":"2013","journal-title":"Cancer Discov."},{"issue":"3","key":"10.1016\/j.bioorg.2021.105505_b0165","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.molcel.2016.09.016","article-title":"Polo-like Kinase-1 Regulates Myc Stabilization and Activates a Feedforward Circuit Promoting Tumor Cell Survival","volume":"64","author":"Xiao","year":"2016","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bioorg.2021.105505_b0170","doi-asserted-by":"crossref","unstructured":"Y. Ren, C. Bi, X. Zhao, T. Lwin, C. Wang, J. Yuan, A.S. Silva, B.D. Shah, B. Fang, T. Li, J.M. Koomen, H. Jiang, J.C. Chavez, L. Pham, P.R. Sudalagunta, L. Wan, X. Wang, W.S. Dalton, L.C. Moscinski, K.H. Shain, J. Vose, J.L. Cleveland, E.M. Sotomayor, K. Fu, J. Tao, PLK1 stabilizes a MYC-dependent kinase network in aggressive B cell lymphomas, J. Clin. Invest. 128 (2018) 5517\u20135530. 10.1172\/jci122533.","DOI":"10.1172\/JCI122533"},{"key":"10.1016\/j.bioorg.2021.105505_b0175","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3390\/cancers13030387","article-title":"A Regulatory Loop of FBXW7-MYC-PLK1 Controls Tumorigenesis of MYC-Driven Medulloblastoma","volume":"13","author":"Wang","year":"2021","journal-title":"Cancers."},{"key":"10.1016\/j.bioorg.2021.105505_b0180","doi-asserted-by":"crossref","unstructured":"J. Hines, S. Lartigue, H. Dong, Y. Qian, C.M. Crews, MDM2-recruiting PROTAC Offers Superior, Synergistic Anti-proliferative Activity via Simultaneous Degradation of BRD4 and Stabilization of p53, Cancer Res. 79 (2018) canres.2918.2018. 10.1158\/0008-5472.can-18-2918.","DOI":"10.1158\/0008-5472.CAN-18-2918"},{"issue":"1","key":"10.1016\/j.bioorg.2021.105505_b0185","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.chembiol.2017.09.010","article-title":"Lessons in PROTAC Design from Selective Degradation with a Promiscuous Warhead","volume":"25","author":"Bondeson","year":"2018","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.bioorg.2021.105505_b0190","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1021\/acschembio.5b00442","article-title":"HaloPROTACS: Use of Small Molecule PROTACs to Induce Degradation of HaloTag Fusion Proteins","volume":"10","author":"Buckley","year":"2015","journal-title":"ACS Chem. Biol."},{"issue":"5","key":"10.1016\/j.bioorg.2021.105505_b0195","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/nchembio.2329","article-title":"Structural basis of PROTAC cooperative recognition for selective protein degradation","volume":"13","author":"Gadd","year":"2017","journal-title":"Nat. Chem. Biol."},{"issue":"8","key":"10.1016\/j.bioorg.2021.105505_b0200","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1007\/s00109-020-01943-6","article-title":"The novel protein homeostatic modulator BTX306 is active in myeloma and overcomes bortezomib and lenalidomide resistance","volume":"98","author":"Zou","year":"2020","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.bioorg.2021.105505_b0205","article-title":"Degradation of Janus kinases in CRLF2- rearranged acute lymphoblastic leukemia","author":"Chang","year":"2021","journal-title":"Blood"}],"updated-by":[{"DOI":"10.1016\/j.bioorg.2024.107248","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000}}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004520682100883X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004520682100883X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T00:48:16Z","timestamp":1729126096000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004520682100883X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":41,"alternative-id":["S004520682100883X"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2021.105505","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.bioorg.2024.107248","asserted-by":"object"}]},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel Cereblon E3 ligase modulator with antitumor activity in gastrointestinal cancer","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2021.105505","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"105505"}}